Skip to main content
      Provacative read from @VPrasadMDMPH on why we no longer need to or should wear masks in our clinics and hospitals (Yes

      Dr. John Cush RheumNow

      2 years 11 months ago
      Provacative read from @VPrasadMDMPH on why we no longer need to or should wear masks in our clinics and hospitals (Yes, with COVID+ pts --- No, everywhere else). My advice: wear masks in high risk environments/situations. https://t.co/cECeieQ2YL https://t.co/PbX8xnfgqM
      RT @DrCassySims: A summary slide from #grandrounds this morning on a talk about trying to differentiate #lupus #nephriti

      Catherine Sims, MD DrCassySims

      2 years 11 months ago
      A summary slide from #grandrounds this morning on a talk about trying to differentiate #lupus #nephritis from #preeclampsia #RheumTwitter #MedTwitter https://t.co/R2rhhgQYIm
      Mayo study of 3817 temporal artery biopsies performed on 2539 pts (1994-2004) - 681 (27%) +Bx on one side. Biopsy length

      Dr. John Cush RheumNow

      2 years 11 months ago
      Mayo study of 3817 temporal artery biopsies performed on 2539 pts (1994-2004) - 681 (27%) +Bx on one side. Biopsy length HAD NO significant effect BX positivity. If 1-side initially Bx-, then Bx of the contralateral side yielded an added 7% Bx positivity https://t.co/Lr8hYHIlG7 https://t.co/alIpklPtsw
      Two large RA registries have shown that pregnancy outcomes in rheumatoid arthritis (RA) patients is more related to RA disease activity rather than treatments use to control RA. 
      Gout Comes With Increased Heart Risk
      • MedPage Today
      Incidence of acute coronary syndrome (ACS) was significantly higher among gout patients than in the general Swedish population, researchers found, even when data were adjusted for common comorbidities.
      Taiwan population study shows increased all-cause mortality for psoriasis patients (HR 1.16; 1.13-1.19) vs. general popu

      Dr. John Cush RheumNow

      2 years 11 months ago
      Taiwan population study shows increased all-cause mortality for psoriasis patients (HR 1.16; 1.13-1.19) vs. general population. https://t.co/p09mXTfXPw https://t.co/UVK3GMMmip
      Study of 247 consecutive PsA pts shows that two-thirds (63.15%) had poor sleep quality. Poorer sleep was assoc w/ being

      Dr. John Cush RheumNow

      2 years 11 months ago
      Study of 247 consecutive PsA pts shows that two-thirds (63.15%) had poor sleep quality. Poorer sleep was assoc w/ being female, higher joint counts, greater peripheral and axial disease activity, but fatigue & anxiety most explained poor sleep quality https://t.co/RTZqxtyIu9 https://t.co/OVtTQkFirD
      Secukinumab retention in PsA: Study of 170 pts, 13% B27+, most w/ peripheral arthritis &70% on 150 mg/mo. Median ret

      Dr. John Cush RheumNow

      2 years 11 months ago
      Secukinumab retention in PsA: Study of 170 pts, 13% B27+, most w/ peripheral arthritis &70% on 150 mg/mo. Median retention 636 days. Peripheral arthritis was a predictor of better retention (HR 0.424). https://t.co/aZD9qD0jxm https://t.co/FlqRlcAZd1
      The Atlantic has published an insightful article on "Brain Fog", especially as a Long Covid consequence (IMHO: Brain fog

      Dr. John Cush RheumNow

      2 years 11 months ago
      The Atlantic has published an insightful article on "Brain Fog", especially as a Long Covid consequence (IMHO: Brain fogs primary cause is poor sleep, fibromyalgia, chronic fatigue - but can be complication to primary CNS events) https://t.co/SlwzRDSVSf https://t.co/qrBvV5oyUA
      Doctor Appointment Wait Times are Up

      Forbes reports that a recent Merritt Hawkins survey shows that patients are waitin

      Dr. John Cush RheumNow

      2 years 11 months ago
      Doctor Appointment Wait Times are Up Forbes reports that a recent Merritt Hawkins survey shows that patients are waiting an average of 26 days for a scheduled appointment with a doctor. https://t.co/oJkLRzRR1y https://t.co/8zy0LgC7dt
      TYK2 Inhibitor FDA Approved for Psoriasis

      BMS made a mega bet on deucravacitinib, an in-house experimental TYK2 drug,

      Dr. John Cush RheumNow

      2 years 11 months ago
      TYK2 Inhibitor FDA Approved for Psoriasis BMS made a mega bet on deucravacitinib, an in-house experimental TYK2 drug, in the leadup to the big Celgene buyout, keeping it while auctioning off Celgene’s top-selling Otezla to Amgen for $13.4 billion https://t.co/wPN62jBIvL https://t.co/Cj6svOoiaJ
      RT @ahomar: I created an online version of the Modified Rodnan Skin Score (mRSS) to make it easier to calculate
      Referen

      A Omar ahomar

      2 years 11 months ago
      I created an online version of the Modified Rodnan Skin Score (mRSS) to make it easier to calculate References mentioned below tool: https://t.co/5Us3usCTsC @SindhuJohnson5 @Janetbirdope #scleroderma #rheum #rheumatology
      RT @ClementsCharl96: Nice table from the Poddubny et al., (2021) study which looks at some of the different characterist

      Charlie Clements ClementsCharl96

      2 years 11 months ago
      Nice table from the Poddubny et al., (2021) study which looks at some of the different characteristics between Axial SpA vs Axial PsA. Axial PsA tends to have; - Less frequent IBP - Less HLAB27 +‘ve - More frequent C-spine involvement https://t.co/XXQKBSfSQq
      RT @LCalabreseDO: In your RHEUMATOLOGY practice how often are you seeing #LongCovid (new fatigue,brainfog,breathless etc

      Leonard Calabrese LCalabreseDO

      2 years 11 months ago
      In your RHEUMATOLOGY practice how often are you seeing #LongCovid (new fatigue,brainfog,breathless etc) in your immune dis pts with COVID ( i.e. > 1 month) @CCalabreseDO @jeffsparks @zach_wallace_md @philipcrobinson @JYazdanyMD @alhkim @RheumNow @EBRheum @rheum_cat @AWIRGROUP
      ×